TP53 and prostate cancer: By using dominant negative p53 (p53DN), p53mt135, to compete with wild-type (WT) p53 in transcription activity in prostate cancer, we demonstrated that p53-mediated apoptosis in response to DOX- or CPT-induced genotoxic stress is transcription-independent.